The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Albemarle reports first quarter 2013 results

Wednesday, April 17, 2013

Albemarle reports first quarter 2013 results

16:03 EDT Wednesday, April 17, 2013

BATON ROUGE, La., April 17, 2013 /PRNewswire/ --

First quarter 2013 highlights:

  • Earnings of $82.7 million, or $0.93 per share, excluding non-operating items.
  • Net sales of $642 million and EBITDA margin, excluding non-operating items, of 22 percent.
  • Increased dividend by 20% and announced intention to repurchase 10% of outstanding shares by end of year.
  • Repurchased approximately 1 million shares in first quarter.

 


Three Months Ended

March 31,

In thousands, except per share amounts

2013

2012

Net sales

$

641,625

$

711,704

Segment income

$

133,625

$

179,763

Net income attributable to Albemarle Corporation

$

83,987

$

114,262

Diluted earnings per share

$

0.94

$

1.27

Non-operating pension and OPEB adjustments(a)

(0.01)

(0.02)

Diluted earnings per share, excluding non-operating items

$

0.93

$

1.25

See accompanying notes and reconciliations to the condensed consolidated financial information.

(Logo: http://photos.prnewswire.com/prnh/20111129/MM14279LOGO)

Albemarle Corporation (NYSE: ALB) reported first quarter 2013 earnings of $84.0 million, or $0.94 per share, compared to first quarter 2012 earnings of $114.3 million, or $1.27 per share.  Excluding non-operating items, first quarter 2013 earnings were $82.7 million, or $0.93 per share, compared to $112.6 million, or $1.25 per share, for 2012.  The Company reported net sales of $641.6 million in the first quarter of 2013 compared to net sales of $711.7 million in the first quarter of 2012, driven by our exit from the phosphorus flame retardants business, lower metals surcharges and pricing on certain products.

"First quarter results matched our expectation that 2013 would begin the year slowly," stated Luke Kissam, CEO.  "Catalysts was impacted by start-up costs from our two greenfield polyolefin catalysts expansions and an unfavorable mix in Refinery Catalysts.  In Fine Chemistry, we saw robust demand for drilling fluids and an expected slow quarter in custom manufacturing.  Polymer Solutions showed modest improvement from fourth quarter, but our current order book patterns suggest that demand for our portfolio of products in consumer electronics, construction and European auto markets will remain sluggish."

Quarterly Segment Results

Catalysts generated net sales of $235.5 million in the first quarter of 2013, a 20 percent decrease from net sales in the first quarter of 2012, due mainly to lower metals surcharges, unfavorable mix and lower overall volumes.  Catalysts segment income was $57.0 million in the first quarter of 2013, down 32 percent from first quarter 2012 results of $83.4 million, due primarily to lower metals surcharges and volumes and unfavorable mix. 

Polymer Solutions reported net sales of $214.8 million in the first quarter of 2013, a 6 percent decrease from net sales in the first quarter of 2012, due to the year-over-year effects of our phosphorus flame retardants business exit in the second quarter of 2012.  Higher sales volumes in our core products were offset by lower pricing and unfavorable mix.  Segment income for Polymer Solutions was $45.3 million in the first quarter of 2013, an 18 percent decline from $55.4 million in the first quarter of 2012, driven by lower pricing, higher variable input costs and unfavorable foreign currency impacts, partly offset by favorable sales volumes and favorable impacts from our exit of the phosphorus flame retardants business.

Fine Chemistry net sales in the first quarter of 2013 were $191.3 million, a 1 percent increase over net sales in the first quarter of 2012, due mainly to favorable sales volume partly offset by unfavorable pricing impacts.  Segment income for Fine Chemistry was $31.4 million for the first quarter of 2013, down 24 percent from first quarter 2012 results of $41.0 million, due to unfavorable pricing, lower factory operating rates and timing of custom services projects.

Corporate and Other

Corporate and other expense was $14.0 million ($16.1 million excluding non-operating items) for the first quarter of 2013.  The $3.6 million decrease from the comparable period in 2012 was due primarily to lower personnel-related costs and other spending.

Interest and financing expenses were $5.2 million for the first quarter of 2013 compared to $8.7 million for the first quarter of 2012, with this decrease due primarily to increases in interest capitalized on higher average construction project balances outstanding and lower variable-rate borrowings year-over-year.

Excluding non-operating items (see notes to the condensed consolidated financial information), our effective income tax rates were 24.6 percent and 26.0 percent for the first quarter of 2013 and 2012, respectively.  Our effective tax rate continues to be influenced by the level and geographic mix of income and benefits from a favorable mix of income in lower tax jurisdictions. 

Cash Flow

Our cash flow from operations was approximately $99 million for the three months ended March 31, 2013, and we had $435 million in cash and cash equivalents at March 31, 2013.  During the three months ended March 31, 2013, cash on hand and cash provided by operations funded capital expenditures for plant, machinery and equipment of approximately $55 million (which includes approximately $19 million in capital expenditures associated with our Jordanian joint venture), dividends to shareholders of $17.8 million and repurchases of $60.8 million, or approximately 1.0 million shares, of our common stock.

Earnings Call

The Company's performance for the first quarter ended March 31, 2013 will be discussed on a conference call at 9:00 AM Eastern Daylight time on April 18, 2013.  The call can be accessed by dialing 888-680-0879 (International Dial-In # 617-213-4856), and entering conference ID 46604711.  The Company's earnings presentation and supporting material can be accessed through Albemarle's website under Investors at www.albemarle.com.

About Albemarle

Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services.  Albemarle is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry.  The Company employs more than 4,000 people worldwide and serves customers in approximately 100 countries.  Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings and other information regarding the Company, its businesses and markets served. 

Forward-Looking Statements

Some of the information presented in this press release and the conference call and discussions that follow, including, without limitation, statements with respect to product development, changes in productivity, market trends, price, volume and mix changes, expected growth and earnings, input costs, surcharges, tax rates, stock repurchases, dividends, economic trends, outlook and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  There can be no assurance that actual results will not differ materially.  Factors that could cause actual results to differ from expectations include, without limitation: changes in economic and business conditions; changes in financial and operating performance of our major customers and industries and markets served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; changes in the cost of raw materials and energy and in our ability to pass through increases; acquisitions and divestitures, and changes in performance of acquired companies; fluctuations in foreign currencies; changes in laws and government regulation impacting our operations or our products; the occurrence of claims or litigation; the occurrence of natural disasters; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest, including terrorism or hostilities; political instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings; changes in monetary policies or inflation or interest rates, which may impact our ability to raise capital or increase our cost of funds, the performance of our pension fund investments and our pension expense and funding obligations; volatility and substantial uncertainties in the debt and equity markets; technology or intellectual property infringement and other innovation risks; decisions we may make in the future; and the other factors detailed from time to time in the reports we file with the SEC, including those described under "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. 

 

Albemarle Corporation and SubsidiariesConsolidated Statements of Income(In Thousands Except Per Share Amounts) (Unaudited)

Three Months Ended

March 31,

2013

2012

Net sales

$

641,625

$

711,704

Cost of goods sold

442,035

460,724

Gross profit

199,590

250,980

Selling, general and administrative expenses(b)

64,750

74,004

Research and development expenses

19,953

19,049

Operating profit

114,887

157,927

Interest and financing expenses

(5,231)

(8,734)

Other expenses, net

(4,209)

(118)

Income before income taxes and equity in net income of unconsolidated

   investments

105,447

149,075

Income tax expense

26,192

39,028

Income before equity in net income of unconsolidated investments

79,255

110,047

Equity in net income of unconsolidated investments (net of tax)

10,261

8,586

Net income

89,516

118,633

Net income attributable to noncontrolling interests

(5,529)

(4,371)

Net income attributable to Albemarle Corporation

$

83,987

$

114,262

Basic earnings per share

$

0.95

$

1.28

Diluted earnings per share

$

0.94

$

1.27

Weighted-average common shares outstanding ? basic

88,719

88,997

Weighted-average common shares outstanding ? diluted

89,236

89,947

See accompanying notes to the condensed consolidated financial information.

 

 

Albemarle Corporation and SubsidiariesCondensed Consolidated Balance Sheets(In Thousands) (Unaudited)

March 31,

December 31,

2013

2012

ASSETS

Cash and cash equivalents

$

434,904

$

477,696

Other current assets

968,596

929,617

Total current assets

1,403,500

1,407,313

Property, plant and equipment

2,850,731

2,818,604

Less accumulated depreciation and amortization

1,532,972

1,522,033

Net property, plant and equipment

1,317,759

1,296,571

Other assets and intangibles

729,186

733,407

Total assets

$

3,450,445

$

3,437,291

LIABILITIES AND EQUITY

Current portion of long-term debt

$

9,228

$

12,700

Other current liabilities

425,023

372,309

Total current liabilities

434,251

385,009

Long-term debt

686,592

686,588

Other noncurrent liabilities

361,102

370,318

Deferred income taxes

66,260

63,368

Albemarle Corporation shareholders' equity

1,797,997

1,833,598

Noncontrolling interests

104,243

98,410

Total liabilities & equity

$

3,450,445

$

3,437,291

See accompanying notes to the condensed consolidated financial information.

 

 

Albemarle Corporation and SubsidiariesSelected Consolidated Cash Flow Data(In Thousands) (Unaudited)

Three Months Ended

March 31,

2013

2012

Cash and cash equivalents at beginning of year

$

477,696

$

469,416

Cash and cash equivalents at end of period

$

434,904

$

519,359

Sources of cash and cash equivalents:

  Net income

$

89,516

$

118,633

  Proceeds from exercise of stock options

1,720

2,569

Uses of cash and cash equivalents:

  Capital expenditures

(55,335)

(54,784)

  Repurchases of common stock

(60,798)

?

  Repayments of long-term debt

(3,604)

(7,149)

  Dividends paid to shareholders

(17,808)

(15,578)

  Pension and postretirement contributions

(1,741)

(2,527)

Non-cash and other items:

  Depreciation and amortization

25,244

24,235

  Pension and postretirement expense

1,582

243

  Equity in net income of unconsolidated investments

(10,261)

(8,586)

See accompanying notes to the condensed consolidated financial information.

 

 

Albemarle Corporation and Subsidiaries Consolidated Summary of Segment Results(In Thousands) (Unaudited)

Three Months Ended

March 31,

2013

2012

Net sales:

Polymer Solutions

$

214,774

$

228,131

Catalysts

235,573

293,522

Fine Chemistry

191,278

190,051

Total net sales

$

641,625

$

711,704

Segment operating profit:

Polymer Solutions

$

43,670

$

54,547

Catalysts

49,045

76,641

Fine Chemistry

36,178

44,363

Total segment operating profit

128,893

175,551

Equity in net income of unconsolidated investments:

Polymer Solutions

2,308

1,845

Catalysts

7,953

6,741

Fine Chemistry

?

?

Corporate & other

?

?

Total equity in net income of unconsolidated investments

10,261

8,586

Net (income) loss attributable to noncontrolling interests:

Polymer Solutions

(708)

(1,002)

Catalysts

?

?

Fine Chemistry

(4,821)

(3,372)

Corporate & other

?

3

Total net income attributable to noncontrolling interests

(5,529)

(4,371)

Segment income:

Polymer Solutions

45,270

55,390

Catalysts

56,998

83,382

Fine Chemistry

31,357

40,991

Total segment income

133,625

179,763

Corporate & other (a)

(14,006)

(17,621)

Interest and financing expenses

(5,231)

(8,734)

Other expenses, net

(4,209)

(118)

Income tax expense

(26,192)

(39,028)

Net income attributable to Albemarle Corporation

$

83,987

$

114,262

See accompanying notes to the condensed consolidated financial information.

 

Notes to the Condensed Consolidated Financial Information

(a)   Non-operating pension and OPEB items, consisting of mark-to-market (MTM) actuarial gains/losses as well as interest costs and expected return on assets, are included in Corporate & other as follows:

  • For the three months ended March 31, 2013 and 2012, net benefits amounting to $2.1 million ($1.3 million after income taxes, or $0.01 per share) and $2.7 million ($1.7 million after income taxes, or $0.02 per share), respectively.  There were no MTM actuarial gains/losses recorded during the three months ended March 31, 2013 and 2012.

Although non-operating pension and OPEB items are included in our GAAP operating profit, we believe that these components of pension cost are mainly driven by market performance, and we manage these separately from the operational performance of our businesses.

(b)   The quarter ended March 31, 2012 includes a gain of $8.1 million ($5.1 million after tax, or $0.06 per share) resulting from proceeds received in connection with the settlement of litigation (net of related legal fees).  The quarter ended March 31, 2012 also includes an $8 million charitable contribution ($5.1 million after tax, or $0.06 per share) to the Albemarle Foundation. 

Additional Information

It should be noted that Net income attributable to Albemarle Corporation ("earnings"), earnings per share and effective income tax rates which exclude non-operating items, as well as presentations of segment operating profit, segment income, EBITDA, EBITDA excluding non-operating items, EBITDA margin and EBITDA margin excluding non-operating items are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP.  These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance.

A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, can be found in the Investors section of our website at www.albemarle.com, under "Non-GAAP Reconciliations" under "Financials."  Also, see attached for a supplemental reconciliation of our segment operating profit and segment income amounts to GAAP Operating profit and GAAP Net income attributable to Albemarle Corporation, respectively, as well as for a supplemental reconciliation of Net income attributable to Albemarle Corporation excluding non-operating items, EBITDA and EBITDA excluding non-operating items to Net income attributable to Albemarle Corporation.

ALBEMARLE CORPORATION AND SUBSIDIARIESNon-GAAP Reconciliation(In Thousands)(Unaudited)

Our segment information includes measures we refer to as "segment operating profit," "segment income," "EBITDA" and "EBITDA excluding non-operating items," which are financial measures that are not required by, or presented in accordance with, GAAP.  The Company has reported segment operating profit, segment income, EBITDA and EBITDA excluding non-operating items because management believes that these financial measures provide transparency to investors and enable period-to-period comparability of financial performance.  Segment operating profit, segment income, EBITDA and EBITDA excluding non-operating items should not be considered as alternatives to operating profit or net income attributable to Albemarle Corporation, as determined in accordance with GAAP.

See below for a reconciliation of segment operating profit and segment income, the non-GAAP financial measures, to Operating profit and Net income attributable to Albemarle Corporation, respectively, the most directly comparable financial measures calculated and reported in accordance with GAAP.

 

Three Months Ended

March 31,

2013

2012

Total segment operating profit

$

128,893

$

175,551

Corporate & other *

(14,006)

(17,624)

GAAP Operating profit

$

114,887

$

157,927

Total segment income

$

133,625

$

179,763

Corporate & other

(14,006)

(17,621)

Interest and financing expenses

(5,231)

(8,734)

Other expenses, net

(4,209)

(118)

Income tax expense

(26,192)

(39,028)

GAAP Net income attributable to Albemarle Corporation

$

83,987

$

114,262

* Excludes corporate equity income and noncontrolling interest adjustments of $3 for the three-month period ended March 31, 2012.

 

See below for a reconciliation of Net income attributable to Albemarle Corporation excluding non-operating items, EBITDA and EBITDA excluding non-operating items, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP.  EBITDA is defined as Net income attributable to Albemarle Corporation before interest and financing expenses, income taxes, depreciation and amortization.  EBITDA excluding non-operating items is defined as EBITDA before the non-operating items as listed below.

 

Three Months Ended

March 31,

2013

2012

Net income attributable to Albemarle Corporation

$

83,987

$

114,262

Add back:

Non-operating pension and OPEB adjustments (net of tax)

(1,297)

(1,703)

Net income attributable to Albemarle Corporation excluding

  non-operating items

$

82,690

$

112,559

Net income attributable to Albemarle Corporation

$

83,987

$

114,262

Add back:

Interest and financing expenses

5,231

8,734

Income tax expense

26,192

39,028

Depreciation and amortization

25,244

24,235

EBITDA

140,654

186,259

Non-operating pension and OPEB adjustments

(2,069)

(2,694)

EBITDA excluding non-operating items

$

138,585

$

183,565

Net sales

$

641,625

$

711,704

EBITDA Margin

21.9

%

26.2

%

EBITDA Margin excluding non-operating items

21.6

%

25.8

%

 

 

SOURCE Albemarle Corporation

For further information: Lorin Crenshaw, 225.388.7322

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

Digital Business Solutions
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections